 With increased transparency requirements and the trend toward global compliance, it is increasingly important to have a holistic approach to grant, HCP and transparency reporting.
IMS Health's end-to-end compliance solutions can help you meet the demands of compliance today while preparing for the future by:
| • |
Automating the grant submission and approval process |
| • |
Streamlining and automating needs assessment, HCP nomination and onboarding, contract creation and management, and activity/meeting data collection |
| • |
Enhancing visibility and control over HCP interactions by tracking, managing and reporting on all HCP financial interactions and sample distribution activity according to state and federal regulations |
With IMS Health, you can easily coordinate your activities between compliance and everyday business practice. Download report now.
With the latest submissions reported to the Centers for Medicaid and Medicare in April, it's a good time to look back and see what the key trends were in the transparency landscape in 2015 and how life sciences companies are tackling growing requirements—including the U.S. Sunshine Law and rules defined by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Review our annual survey on aggregate spend and transparency, 2015 U.S. Trends in Aggregate Spend, Disclosure and Transparency, here. |
